Patents by Inventor Yu-Hsun Kao

Yu-Hsun Kao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230177852
    Abstract: A high-speed automatic scanning system for interpreting images with AI assistance and method using the same are provided. The system includes a control computer and an image capture platform. Scanning parameters of the image capture platform, including a helically-clockwise or helically-counterclockwise scanning path, is set by the control computer. After the scanning path is selected, the image capture platform aligns a camera to focus on a central block and respectively captures images of the central block's sub-blocks. Until all the blocks have been scanned, the image capture platform repeats the following procedure: moving the focusing position to a next neighboring block according to the scanning path, focusing on the next neighboring block, and capturing images of the sub-blocks of the next neighboring block. The present invention can fast perform scanning, exempted from performing focusing for every image, reducing the cycles and time of focusing.
    Type: Application
    Filed: December 22, 2021
    Publication date: June 8, 2023
    Inventors: TZU-KUEI SHEN, KUO-TUNG HUNG, CHIEN TING YANG, YU HSUN KAO, GUANG-HAO SUEN, LINDA SIANA
  • Patent number: 11580643
    Abstract: A system for facilitating medical image interpretation includes a processing unit and a display control unit. The processing unit includes a location information module generating a reference location indicator, and a feature marking module generating indication markers. The display control unit is in signal connection with the processing unit and a display device. The display control unit includes an image displaying module controlling the display device to display tissue images, and an auxiliary information displaying module controlling the display device to display, for each of the tissue images displayed by the display device, the reference location indicator and the indication markers together on the tissue image.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: February 14, 2023
    Assignee: V5 TECHNOLOGIES CO., LTD.
    Inventors: Chien-Chung Huang, Chien-Ting Yang, Tzu-Kuei Shen, Yu-Hsun Kao, Kuo-Tung Hung, Yueh-Heng Lee
  • Publication number: 20210366117
    Abstract: A system for facilitating medical image interpretation includes a processing unit and a display control unit. The processing unit includes a location information module generating a reference location indicator, and a feature marking module generating indication markers. The display control unit is in signal connection with the processing unit and a display device. The display control unit includes an image displaying module controlling the display device to display tissue images, and an auxiliary information displaying module controlling the display device to display, for each of the tissue images displayed by the display device, the reference location indicator and the indication markers together on the tissue image.
    Type: Application
    Filed: September 30, 2020
    Publication date: November 25, 2021
    Inventors: Chien-Chung HUANG, Chien-Ting YANG, Tzu-Kuei SHEN, Yu-Hsun KAO, Kuo-Tung HUNG, Yueh-Heng LEE
  • Patent number: 9296692
    Abstract: Novel use of small molecules, particularly indolyl and indolinyl hydroxamates is disclosed herein. The indolyl and indolinyl hydroxamates are useful as lead compounds for manufacturing a medicament or a pharmaceutical composition for treating a patient suffering from heart failure or neuronal injury.
    Type: Grant
    Filed: September 15, 2012
    Date of Patent: March 29, 2016
    Assignee: TAIPEI MEDICAL UNIVERSITY
    Inventors: Yi-Jen Chen, Kuo-Sheng Hung, Yu-Hsun Kao, Jing-Ping Liou, Pei-Wen Shan
  • Publication number: 20150065552
    Abstract: Novel use of small molecules, particularly indolyl and indolinyl hydroxamates is disclosed herein. The indolyl and indolinyl hydroxamates are useful as lead compounds for manufacturing a medicament or a pharmaceutical composition for treating a patient suffering from heart failure or neuronal injury.
    Type: Application
    Filed: September 15, 2012
    Publication date: March 5, 2015
    Applicant: Taipei Medical University
    Inventors: Yi-Jen Chen, Kuo-Sheng Hung, Yu-Hsun Kao, Jing-Ping Liou, Pei-Wen Shan